These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7817424)

  • 1. [Reversibility test in obstructive lung disease. Use and limitations].
    Ringbaek TJ; Lange P
    Ugeskr Laeger; 1994 Nov; 156(48):7185-8. PubMed ID: 7817424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative spirometry and perioperative drug therapy in patients with obstructive pulmonary dysfunction.
    Takiguchi H; Niimi K; Tomomatsu H; Tomomatsu K; Hayama N; Oguma T; Aoki T; Urano T; Asai S; Miyachi H; Abe T; Asano K
    Tokai J Exp Clin Med; 2014 Sep; 39(3):151-7. PubMed ID: 25248432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual Volume and Total Lung Capacity to Assess Reversibility in Obstructive Lung Disease.
    McCartney CT; Weis MN; Ruppel GL; Nayak RP
    Respir Care; 2016 Nov; 61(11):1505-1512. PubMed ID: 27555617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility.
    Zhao H; Li R; Lv Y; Dong H; Yao L; Wu Y; Xiao G; Cai S
    Clin Respir J; 2017 May; 11(3):328-336. PubMed ID: 26077165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment of obstructive lung diseases].
    Kolle S; Mørkve O
    Tidsskr Nor Laegeforen; 1998 Sep; 118(21):3268-71. PubMed ID: 9772813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled therapy in COPD: what are the benefits?
    Postma DS
    Respir Med; 1991 Nov; 85(6):447-9. PubMed ID: 1775669
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Utility of Additional Measurement of Total Lung Capacity in Diagnosing Obstructive Lung Disease in Subjects With Restrictive Pattern of Spirometry.
    Lee H; Chang B; Kim K; Song WJ; Chon HR; Kang HK; Kim JS; Jeong BH; Oh YM; Koh WJ; Park HY
    Respir Care; 2016 Apr; 61(4):475-82. PubMed ID: 26884447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
    Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?
    Melbye H; Al-Ani S; Spigt M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3145-3152. PubMed ID: 27994453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchial responsiveness in patients with restrictive spirometry.
    Keddissi JI; Elya MK; Farooq SU; Youness HA; Jones KR; Awab A; Kinasewitz GT
    Biomed Res Int; 2013; 2013():498205. PubMed ID: 24024196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Response to inhaled bronchodilators in chronic airway obstruction].
    Holten K
    Tidsskr Nor Laegeforen; 1993 Feb; 113(4):444-7. PubMed ID: 8465284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FVC response in bronchoreversibility test.
    Chhabra SK
    Indian J Chest Dis Allied Sci; 2001; 43(1):9-11. PubMed ID: 11370510
    [No Abstract]   [Full Text] [Related]  

  • 14. PEF versus FEV1.
    Gregg I
    Thorax; 2000 Sep; 55(9):807. PubMed ID: 11012369
    [No Abstract]   [Full Text] [Related]  

  • 15. Spirometric indices after bronchodilator test in obstructive lung disease.
    Mehrparvar AH; Mirmohammadi SJ; Sohrabi MM
    Acta Med Iran; 2010; 48(4):226-30. PubMed ID: 21279934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchodilator response of advanced lung function parameters depending on COPD severity.
    Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measures of bronchodilator response of FEV
    Torén K; Bake B; Olin AC; Engström G; Blomberg A; Vikgren J; Hedner J; Brandberg J; Persson HL; Sköld CM; Rosengren A; Bergström G; Janson C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():973-980. PubMed ID: 28356729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A regular or an intermittent treatment for asthma: the long-term effect.
    Sposato B; Pammolli A; Bove L; Barzan R; Ricci A; Scalese M; Marioita S; Franco C
    Eur Rev Med Pharmacol Sci; 2010 Dec; 14(12):1037-44. PubMed ID: 21375136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing obstructive lung disease. Why is differentiating COPD from asthma important?
    Subramanian D; Guntupalli KK
    Postgrad Med; 1994 Jun; 95(8):69-70, 75-8, 83-5. PubMed ID: 8202424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.